RSU grant boosts Oncology Institute (NASDAQ: TOI) admin chief stake

Rhea-AI Filing Summary

England Kristin reported acquisition or exercise transactions in this Form 4 filing.

Oncology Institute, Inc. reported that Chief Administrative Officer Kristin England received a grant of 55,743 shares of common stock in the form of restricted stock units (RSUs) at no cash cost. Following this award, she directly holds 153,780 shares of the company’s common stock.

The RSUs vest over four years, with one quarter vesting on the first anniversary of the vesting commencement date and the remaining three quarters vesting in equal annual installments on each of the next three anniversaries, subject to her continued service with the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider England Kristin

Role Chief Administrative Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	55,743	$0.00	--

Holdings After Transaction: Common Stock — 153,780 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 55,743 shares Total holdings after grant: 153,780 shares Grant price per share: $0.00 per share +2 more

5 metrics

RSUs granted 55,743 shares Restricted stock unit award to Chief Administrative Officer

Total holdings after grant 153,780 shares Direct common stock ownership following RSU award

Grant price per share $0.00 per share Compensation award, not open-market purchase

Initial vesting portion 1/4 of RSUs Vests on first anniversary of vesting commencement date

Remaining vesting period 3 equal annual installments Vests over next three anniversaries, for four years total

Key Terms

Restricted Stock Units, RSU, Vesting Commencement Date, continued service

4 terms

Restricted Stock Units financial

"Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU financial

"Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

Vesting Commencement Date financial

"on the first anniversary of the Vesting Commencement Date, with the remaining RSUs"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

continued service financial

"subject to continued service with the Company through such vesting dates"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

England Kristin

(Last) (First) (Middle)

C/O ONCOLOGY INSTITUTE, INC.

18000 STUDEBAKER ROAD, SUITE 800

(Street)

CERRITOS CALIFORNIA 90703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oncology Institute, Inc. [ TOI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Administrative Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/27/2026		A		55,743(1)	A	$0	153,780	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates

	Mark Hueppelsheuser, Attorney-in-fact for Kristin England	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TOI report for Kristin England?

Oncology Institute, Inc. reported that Chief Administrative Officer Kristin England received a grant of 55,743 restricted stock units. These RSUs represent shares of common stock awarded as compensation, increasing her direct holdings to 153,780 shares after the transaction.

How many TOI shares were granted in Kristin England’s RSU award?

Kristin England received 55,743 restricted stock units tied to Oncology Institute common stock. The grant was recorded at a price per share of $0.00, reflecting a compensation award rather than an open-market purchase involving cash consideration from the executive.

What is Kristin England’s total TOI ownership after this Form 4 filing?

After the RSU grant, Kristin England directly holds 153,780 shares of Oncology Institute common stock. This total includes the newly awarded 55,743 restricted stock units, which will convert into shares as they vest over the specified four-year schedule.

How do the RSUs for TOI’s Chief Administrative Officer vest over time?

The RSUs vest over four years. One quarter of the 55,743 units vests on the first anniversary of the vesting commencement date, and the remaining units vest in three equal annual installments, contingent on her continued service with Oncology Institute through each vesting date.

Is Kristin England’s RSU grant in TOI an open-market stock purchase?

No, the transaction is classified as a grant or award acquisition, not an open-market purchase. The RSUs were granted at a reported price of $0.00 per share, indicating a compensation award rather than shares bought in the market by Kristin England.